THC THERAPEUTICS, INC. Retained Earnings
THC THERAPEUTICS, INC. had Retained Earnings of -$39.24 million as of 2024-07-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-02-27
- 2024-07-31: Retained Earnings (Accumulated Deficit) -$39.24M.
- 2024-04-30: Retained Earnings (Accumulated Deficit) -$38.95M.
- 2024-01-31: Retained Earnings (Accumulated Deficit) -$39.06M.
- 2023-10-31: Retained Earnings (Accumulated Deficit) -$38.49M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2024-07-31 | -$39.24M 10-K · filed 2026-02-27 | |
| 2024-04-30 | -$38.95M 10-Q · filed 2024-11-13 | |
| 2024-01-31 | -$39.06M 10-Q · filed 2024-09-05 | |
| 2023-10-31 | -$38.49M 10-Q · filed 2024-08-09 | |
| 2023-07-31 | -$38.42M 10-K · filed 2026-02-27 | |
| 2023-04-30 | -$38.39M 10-Q · filed 2024-01-09 | |
| 2023-01-31 | -$38.49M 10-Q · filed 2024-01-08 | |
| 2022-10-31 | -$40.17M 10-Q · filed 2022-12-22 | |
| 2022-07-31 | -$38.04M 10-K · filed 2024-02-26 | |
| 2022-04-30 | -$38.39M 10-Q · filed 2022-06-16 | |
| 2022-01-31 | -$37.76M 10-Q · filed 2022-05-16 | |
| 2021-10-31 | -$37.00M 10-Q · filed 2022-05-16 | |
| 2021-07-31 | -$36.52M 10-K · filed 2022-11-25 | |
| 2021-04-30 | -$35.43M 10-Q · filed 2021-06-22 | |
| 2021-01-31 | -$35.08M 10-Q · filed 2021-03-29 | |
| 2020-10-31 | -$34.72M 10-Q · filed 2020-12-17 | |
| 2020-07-31 | -$34.63M 10-K · filed 2022-03-31 | -$34.63M 10-K · filed 2020-11-04 |
| 2020-04-30 | -$34.97M 10-Q · filed 2020-06-22 | |
| 2020-01-31 | -$33.71M 10-Q · filed 2020-03-23 | |
| 2019-10-31 | -$32.85M 10-Q · filed 2019-12-23 | |
| 2019-07-31 | -$32.70M 10-K · filed 2020-11-04 | |
| 2019-04-30 | -$35.51M 10-Q · filed 2019-06-14 | |
| 2019-01-31 | -$13.38M 10-Q · filed 2019-03-15 | |
| 2018-10-31 | -$9.83M 10-Q · filed 2018-12-19 | |
| 2018-07-31 | -$9.39M 10-K/A · filed 2019-11-18 |